Thank you skepticone. I liked the Ops manager, I had a chance to talk to him a few times in the past and he always impressed me with his objectivity.
I am somewhat taken by surprise how deeply the exoskeleton publicly traded companies have entered into bear territory. Ekso, ReWalk, Bionik Labs, and Cyberdyne are at a lower level compared to just a few weeks ago. Bioservo is holding steady but they had a sizable injection of funds recently.
I am starting to think that my editor is correct and I am underestimating how awkward and "ugly" exoskeletons look to the common eye and that there is an adoption/perception barrier that will have to cleared.
News 
Market Data 
Discover 
